53
In band
Moving averages
SMA 200$12.95-3.71%
Company profile
Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$1.74B
P/E ratioNone
EPS$-3.35
Beta1.801
Dividend yield0.00%
52-week high$28.25
52-week low$7.95
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
GPCR
Structure Therapeutics Inc
RSI 27
SRPT
Sarepta Therapeutics Inc
RSI 51
NVAX
Novavax Inc
RSI 45
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
AUPH
Aurinia Pharmaceuticals Inc
RSI 49
GHRS
GH Research PLC
RSI 48
RSI alerts for NTLA
An email when NTLA closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:54 PM EDT